Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 21% ± 3% | |
glutamatergic neuron | 3 studies | 31% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 721.04 | 1445 / 1445 | 100% | 14.40 | 183 / 183 |
brain | 100% | 767.84 | 2640 / 2642 | 100% | 19.66 | 705 / 705 |
ovary | 100% | 854.91 | 180 / 180 | 99% | 10.21 | 425 / 430 |
breast | 100% | 862.76 | 459 / 459 | 98% | 14.80 | 1101 / 1118 |
lung | 100% | 669.16 | 576 / 578 | 99% | 12.71 | 1141 / 1155 |
uterus | 100% | 906.24 | 170 / 170 | 98% | 12.57 | 450 / 459 |
bladder | 100% | 804.52 | 21 / 21 | 97% | 12.86 | 491 / 504 |
prostate | 100% | 704.95 | 245 / 245 | 97% | 10.47 | 486 / 502 |
thymus | 100% | 876.99 | 653 / 653 | 97% | 7.94 | 585 / 605 |
pancreas | 100% | 413.46 | 327 / 328 | 97% | 8.37 | 172 / 178 |
intestine | 100% | 757.49 | 966 / 966 | 95% | 13.02 | 502 / 527 |
stomach | 99% | 532.11 | 357 / 359 | 95% | 12.33 | 272 / 286 |
adrenal gland | 100% | 645.60 | 258 / 258 | 93% | 9.23 | 215 / 230 |
skin | 100% | 847.26 | 1808 / 1809 | 90% | 13.21 | 426 / 472 |
kidney | 100% | 550.45 | 89 / 89 | 88% | 6.82 | 794 / 901 |
liver | 97% | 322.82 | 220 / 226 | 86% | 6.37 | 348 / 406 |
adipose | 100% | 837.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 787.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 822.48 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 572.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.98 | 1 / 1 |
heart | 98% | 511.47 | 842 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.06 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 55% | 5.97 | 44 / 80 |
peripheral blood | 53% | 500.09 | 489 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043248 | Biological process | proteasome assembly |
GO_0008283 | Biological process | cell population proliferation |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0016281 | Cellular component | eukaryotic translation initiation factor 4F complex |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | OTUD6B |
Protein name | OTU deubiquitinase 6B ubiquitinyl hydrolase 1 (EC 3.4.19.12) Deubiquitinase OTUD6B (EC 3.4.19.12) (DUBA-5) (OTU domain-containing protein 6B) |
Synonyms | hCG_32310 DUBA5 CGI-77 |
Description | FUNCTION: [Isoform 1]: Deubiquitinating enzyme that may play a role in the ubiquitin-dependent regulation of protein synthesis, downstream of mTORC1 . May associate with the protein synthesis initiation complex and modify its ubiquitination to repress translation . May also repress DNA synthesis and modify different cellular targets thereby regulating cell growth and proliferation . May also play a role in proteasome assembly and function . .; FUNCTION: [Isoform 2]: Stimulates protein synthesis. Influences the expression of CCND1/cyclin D1 by promoting its translation and regulates MYC/c-Myc protein stability. . |
Accessions | Q8N6M0 ENST00000617869.4 ENST00000522894.5 ENST00000404789.8 [Q8N6M0-1] A0A0C4DH76 A0A087X0W9 ENST00000285420.8 ENST00000615618.1 [Q8N6M0-2] |